Showing results (801-810 of 1,877) with videos related to
Sort By:
Pageof 188
Immunotherapy|November 29, 2016
Evaluation of efficacy and safety of different pembrolizumab dose/schedules in treatment of non-small-cell lung cancer and melanoma: a systematic reviewOmar Abdel-RahmanImmunotherapy|February 5, 2014
Cancer-testis genes as candidates for immunotherapy in breast cancerSoudeh Ghafouri-Fard, Roshanak Shamsi, Mahnaz Seifi-Alan, et al.Immunotherapy|April 5, 2019
Prognostic impact of neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysisVincenzo Di Nunno, Veronica Mollica, Lidia Gatto, et al.Immunotherapy|April 5, 2019
Hypereosinophilia in a patient with metastatic non-small-cell lung cancer treated with antiprogrammed cell death 1 (anti-PD-1) therapyYanyan Lou, Julian A Marin-Acevedo, Prakash Vishnu, et al.Immunotherapy|March 18, 2017
Neoepitopes as cancer immunotherapy targets: key challenges and opportunitiesCory A Brennick, Mariam M George, William L Corwin, et al.Immunotherapy|May 13, 2014
Akt2 deficiency as a therapeutic strategy protects against acute lung injuryAdrienne E Gauna, Seunghee ChaImmunotherapy|May 13, 2014
Dendritic cell vaccine against leukemia: advances and perspectivesDige Andom TesfatsionImmunotherapy|March 1, 2021
Use of immune checkpoint inhibitors in cancer patients with pre-existing sarcoidosisSang T Kim, Xerxes Pundole, Ramona Dadu, et al.Immunotherapy|November 12, 2021
Potential biomarkers and resistance mechanisms of atezolizumab in a patient with lung squamous cell carcinomaKangqi Ren, Quanzhou Peng, Guanggui Ding, et al.Immunotherapy|November 8, 2021
A common approach for fighting tuberculosis and leprosy: controlling endoplasmic reticulum stress in myeloid-derived suppressor cellsNirmal Kumar, Nabab Khan, Dawn Cleveland, et al.Pageof 188